Skip to content

Vitoss 2102-1305Recalls & reported problems

Stryker Corporation · Bone Graft Substitute, Foam Flow, Beta-Tricalcium Phosphate and Type I Bovine Collagen · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00808232000375), received between Dec 6, 2016 and Dec 6, 2016 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Expiration Issue” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Device Expiration Issue1
  • Use of Device Problem1

Patient problems

  • No Consequences Or Impact To Patient1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 6, 2016Use of Device Problem; Device Expiration Issue; Use of Device Problem

    IT WAS REPORTED THAT A PIECE OF 2102-1305, LOT # B1310001 WHICH WAS EXPIRED ON 10/31/2016 WAS IMPLANTED INTO A PATIENT ON (B)(6) 2016.

    Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient

    MAUDE report 6148560 ↗

Other FILLER, BONE VOID, CALCIUM COMPOUND devices

All FILLER, BONE VOID, CALCIUM COMPOUND devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page